Search Results (76)

Macroalgae (seaweeds) produce unique bioactive metabolites that have enabled their survival for millions of years, offering significant potential for human benefits. In the Israeli Mediterranean Sea, no comprehensive systematic surveys of seaweeds have been published since the 1990s, and their chemical composition remains largely unexplored. This study presents an extensive survey of intertidal seaweed communities along the shallow Israeli coastline, documenting their spatial, temporal, and biochemical diversity. Of the 320 specimens collected, 55 seaweed species were identified: 29 red (Rhodophyta), 14 brown (Phaeophyceae), and 12 green (Chlorophyta). A significant shift in species abundance was documented, with a single dominant annual bloom occurring during spring, unlike previously reported biannual blooms. Chemical analysis of the dominant species revealed significant seasonal variations in compound levels, with higher protein content in winter and increased antioxidant capacity during spring. Phenolic and natural sunscreen compounds (mycosporine-like amino acids, MAAs) showed no general seasonal trend. These findings highlight the optimal environmental conditions for seaweed growth and underscore their potential for aquaculture and biotechnology. We hypothesize that the ecologically unique conditions of the Israeli Mediterranean Sea may foster resilient seaweed species enriched with distinctive chemical properties, suitable for nutritional, health, pharmaceutical, and nutraceutical applications, particularly as climate-adaptive bioresources. Full article

The rapid expansion of shrimp aquaculture has led to the generation of nutrient-rich effluents, which contribute to environmental degradation if inadequately managed. This study evaluated the potential of Dunaliella salina for the reuse of shrimp aquaculture wastewater (SAW) in biofloc production systems under varying dilution levels (0%, 25%, and 50%) and the simultaneous production of high-value biomass. Growth kinetics were modeled using a four-parameter logistic model, and nutrient removal, biochemical composition, and fatty acid profile were assessed. D. salina exhibited substantial growth in undiluted SAW, achieving over 80% removal of total nitrogen and reducing the organic load, as measured by a chemical oxygen demand reduction of more than 79%. In SAW treatments, the protein content ranged from 24.7% to 26.3%, while the lipid content reached up to 67.1% in a 25% SAW dilution. Chlorophyll a and total carotenoids were measured at 5.3–7 µg/mL and 4.1–5.7 µg/mL, respectively, in SAW treatments. The polyunsaturated fatty acid content in undiluted SAW was 34.5%, with α-linolenic acid (C18:3n3) and linoleic acid (C18:2n6) comprising 12% and 7.5%, respectively. This study demonstrates the ability of D. salina to valorize shrimp aquaculture wastewater in biofloc systems into lipid-rich, bioactive biomass, supporting its use in integrated aquaculture biotechnology systems for sustainable wastewater management and bioproduct generation. Full article

Microalgae are a subject of interest not only for fundamental research but for various biotechnological applications as well. In this study, the ability of newly isolated strains, i.e., Picochlorum costavermella VAS2.5, Picochlorum oklahomense SAG4.4, Microchloropsis gaditana VON5.3, and Nephroselmis pyriformis PAT2.7, to grow when cultured in an open raceway pond under laboratory conditions and produce various metabolites of high-added value was evaluated. N. pyriformis PAT2.7 and P. costavermella VAS2.5 were the greatest in biomass production (exceeding 0.4 g/L), while P. costavermella VAS2.5 and M. gaditana VON5.3 were the greatest in lipid production (reaching approximately 18%, wt/wt). The lipid fraction of glycolipids and sphingolipids was predominant (43.6–55.4%, wt/wt), followed by neutral lipids (27.1–50.1%, wt/wt) and phospholipids (6.9–17.4%, wt/wt). Picochlora and M. gaditana VON5.3 lipids were rich in ^{Δ5,8,11,14,17}C20:5 and/or ^Δ9,12,15C18:3, while N. pyriformis PAT2.7 synthesized ^Δ9C16:1 in large quantities (30–40%, wt/wt). All strains showed remarkable yields in polysaccharide and protein production, demonstrated a well-balanced amino acid profile, and synthesized pigments in amounts comparable to other studies. The biochemical profiles of these strains showcased their suitability for use primarily in the aquaculture sector. Full article

The microalgal strains Picochlorum costavermella VAS2.5, Picochlorum oklahomense SAG4.4, Picochlorum oklahomense PAT3.2B, Microchloropsis gaditana VON5.3, and Nephroselmis pyriformis PAT2.7 were cultured in a Stirred Tank Reactor at 25 °C or 20 °C in modified artificial seawater and their biotechnological potential was assessed. VAS2.5, VON5.3, and PAT2.7 were high in biomass production at both temperatures (i.e., 438.8–671.3 mg/L and 418.4–546.7 mg/L at 25 °C and 20 °C, respectively), though P. oklahomense strains grew only at 25 °C. The highest lipid percentage was recorded for the cultures of VAS2.5 (19.3 ± 0.7%) and VON5.3 (16.4 ± 1.5%) at 25 °C, notably rich in ^{Δ5,8,11,14,17}C20:5, while PAT2.7 proved a major producer of ^Δ9C16:1. The predominant lipid fraction was glycolipids and sphingolipids (41.3–57.4%) for VAS2.5, PAT2.7 at 25 °C and VON5.3 at 20 °C and neutral lipids (55.6–63.5%) in the other cultures, indicating the different effect of temperature on lipid synthesis of the various microalgae. Additionally, almost all strains stood out for their high protein content, exceeding 50% in the culture of PAT3.2B, but polysaccharide and pigment content were not high. The biochemical profiles of the isolates showcased their suitability for use primarily as feed additives in the aquaculture sector. Full article

This study investigates the synergistic effects of integrating ozone nanobubbles (generated via a pure oxygen-fed reactor with nanobubble-diffusing air stones) and biofloc technology (BFT) on water quality optimization, pathogenic load reduction, and growth performance enhancement in Pacific white shrimp (Penaeus vannamei) prenursery aquaculture systems. Four treatments were tested: a clear water control (CW), ozonated clear water (CW + O), biofloc (FLOC), and biofloc with ozone (FLOC + O). The FLOC + O group significantly improved water quality, reducing total ammonia nitrogen (TAN) by 61%, nitrite nitrogen (NO₂⁻-N) by 78% compared to CW, and total suspended solids (TSS) by 21% compared to FLOC (p = 0.0015). Ozone application (maintained above 0.3 mg/L, 15 min/day) demonstrated robust pathogen suppression, achieving a sharp reduction in Muscle Necrosis Virus (MNV), a 99.5% inhibition of Vibrio spp. (from 228,885 to 107 CFU/mL), and the clearance of Epistylis spp., as determined via optical microscope. These enhancements directly translated to superior biological outcomes, with the FLOC + O group exhibiting an 82% survival rate (vs. 40% in CW) and 13% higher final body weight (11.65 mg vs. 10.32 mg in CW). The integration of ozone and BFT also accelerated larval development and improved the Zoea II to Mysis I metamorphosis success rate. By maintaining stable microbial communities and reducing organic waste, the combined system lowered the water exchange frequency by 40% and eliminated the need for prophylactic antibiotics. These results demonstrate that ozone–BFT integration effectively addresses key challenges in shrimp prenursery—enhancing disease resistance, optimizing water conditions, and improving growth efficiency. The technology offers a sustainable strategy for the intensive prenursery of Pacific white shrimp, balancing ecological resilience with production scalability. Full article

Research increasingly highlights jellyfish as a sustainable alternative to other animal species, particularly for its collagen, which has versatile applications in blue biotechnology. This review explores the properties of jellyfish-derived collagen, extraction techniques, and its diverse industrial applications based on the current scientific literature. With a particular focus on research in the Mediterranean Sea, we underscore the role of the order Rhizostomeae as jellyfish species with high collagen content and provide an overview of the main sources for jellyfish harvesting, including active fishing, by-catch, and aquaculture. In the Mediterranean basin, the blooming species Rhizostoma pulmo, Cotylorhiza tuberculata, and Rhopilema nomadica represent a valuable opportunity to harness their nutraceutical benefits, as well as their potential for the development of biomaterials in tissue engineering and regenerative medicine. Although jellyfish fishing is not yet well-established in the region, ongoing collaborative projects with fishermen’s guilds are focused on promoting circular and blue economy strategies to valorize jellyfish as an innovative resource. Additionally, jellyfish aquaculture emerges as a promising alternative for ensuring a sustainable supply, with the Rhizostomeae Cassiopea spp. demonstrating significant potential for biotechnological applications. Full article

Lactic acid bacteria (LAB) play a crucial role in probiotics, functional foods, and sustainable biotechnologies due to their ability to produce bioactive metabolites such as short-chain fatty acids, bacteriocins, vitamins, and exopolysaccharides. These metabolites aid in gut health, pathogen inhibition, and enhanced productivity in the food, pharmaceutical, and aquaculture industries. However, the high production cost remains a major challenge, necessitating cost-effective media formulations and bioprocess optimization. This review explores strategies for maximizing LAB yields and functionality through the precision control of key cultivation parameters, including temperature, pH, and agitation speed, ensuring probiotic viability in compliance with regulatory standards (≥10⁶ CFU/g or mL). Furthermore, advances in metabolic engineering, synthetic biology, and the utilization of agro-industrial by-products are driving cost-efficient and eco-friendly LAB production. By integrating scalable fermentation technologies with sustainable resource management, LAB have the potential to bridge the gap between food security, environmental sustainability, and biotechnological innovation. This review provides a comprehensive overview of recent advances in LAB cultivation and bioprocess optimization, ensuring high-quality probiotic production for diverse industrial applications. Full article

The expansion of fisheries and aquaculture in recent decades has led to a substantial increase in fish by-products. This study investigates the extraction and characterization of calcium phosphates from the by-products of representative species in these industries, aiming to identify potential sources for biotechnological and pharmaceutical applications. Clean bones obtained by enzyme hydrolysis from the heads, central skeletons, and/or tails of Atlantic horse mackerel, blue whiting, hake, mackerel, and farmed turbot were subjected to calcination to obtain calcium phosphates. The clean bone content in terms of nitrogen, lipids, organic matter, total protein, and amino acids was evaluated together with the chemical bonds, structures, and elemental composition of calcium phosphates. Results indicated a significantly higher yield of wet bone recovery (23%, p < 0.05) for the central skeleton of Atlantic horse mackerel and the highest mineral fraction for the heads of Atlantic horse mackerel (73.2%), followed by that of blue whiting (72.6%). Hake and turbot presented the lowest mineral fractions and, therefore, the highest protein content (27–31%, p < 0.05), with significant levels of collagen-related amino acids (p < 0.05). X-ray diffraction (XRD) and Fourier-transform Raman spectroscopy (FT-Raman) confirmed the biphasic calcium phosphate composition for most samples based on hydroxyapatite with contributions of whitlockite/β-tricalcium phosphate. The highest contribution to the non-apatite phase was made by the central skeletons of both mackerel and Atlantic horse mackerel. Full article

The extensive use of pharmaceuticals in human and veterinary medicine has led to their persistent environmental release, posing ecological and public health risks. Major sources include manufacturing effluents, excretion, aquaculture, and improper disposal, contributing to bioaccumulation and ecotoxicity. Mycoremediation is the fungal-mediated biodegradation of pharmaceuticals, offers a promising and sustainable approach to mitigate pharmaceutical pollution. Studies have reported that certain fungal species, including Trametes versicolor and Pleurotus ostreatus, can degrade up to 90% of pharmaceutical contaminants, such as diclofenac, carbamazepine, and ibuprofen, within days to weeks, depending on environmental conditions. Fungi produce a range of extracellular enzymes, such as laccases and peroxidases, alongside intracellular enzymes like cytochrome P450 monooxygenases, which catalyze the transformation of complex pharmaceutical compounds. These enzymes play an essential role in modifying, detoxifying, and mineralizing xenobiotics, thereby reducing their environmental persistence and toxicity. The effectiveness of fungal biotransformation is influenced by factors such as substrate specificity, enzyme stability, and environmental conditions. Optimal degradation typically occurs at pH 4.5–6.0 and temperatures of 20–30 °C. Recent advancements in enzyme engineering, immobilization techniques, and bioreactor design have improved catalytic efficiency and process feasibility. However, scaling up fungal-based remediation systems for large-scale applications remains a challenge. Addressing these limitations with synthetic biology, metabolic engineering, and other biotechnological innovations could further enhance the enzymatic degradation of pharmaceuticals. This review highlights the enzymatic innovations, applications, and challenges of pharmaceutical mycoremediation, emphasizing the potential of fungi as a transformative solution for sustainable pharmaceutical waste management. Full article

The marine oleaginous microalga Microchloropsis gaditana (formerly Nannochloropsis gaditana) exhibits a high capacity to thrive in a broad range of environmental conditions, being predominantly utilized as feed in aquaculture. This article reports the characterization of the culturable yeast population present during the scale-up process of M. gaditana cultivation at Necton S.A. facilities, from 5 L flasks until tubular photobioreactors. The 146 yeast isolates obtained, molecularly identified based on D1/D2 and ITS nucleotide sequences, belong to the species Rhodotorula diobovata, R. mucilaginosa, R. taiwanensis, R. sphaerocarpa, Vishniacozyma carnescens, Moesziomyces aphidis, and Meyerozyma guilliermondii. The yeast abundance was found to increase throughout upscaling stages. The yeast populations isolated from microalgal cultures and water samples share phylogenetically close isolates, indicating a possible common source. The impressive high percentage of red yeasts isolated (90%) is consistent with the recognized role of carotenoid pigments in yeast photoprotection. Sixty yeast isolates were tested for lipid (Nile Red staining) and biosurfactant (oil drop dispersion and emulsification index) production. Results revealed that these capacities are common features. Microbial lipids and biosurfactants have promising biotechnological applications. Moreover, biosurfactants can fulfill various physiological roles and provide advantages in natural environments contributing to the promising use of yeasts as probiotics in microalgae production. Full article

Biopolymers, such as polysaccharides, polyphenols, alkaloids, and terpenoids, found in marine algae exhibit antiviral and anticancer properties. These compounds can inhibit viral replication, induce apoptosis in cancer cells, and enhance the immune response. Their diverse bioactive properties make marine algae a promising source for the development of sustainable antiviral and anticancer therapies. A major advantage of marine algae is that they do not require freshwater or arable land and can be cultivated in seawater, thus making them sustainable substitutes for conventional resources. Additionally, their ability to sequester carbon and recycle nutrients enhances their environmental sustainability. Despite their promising biomedical potential, challenges, such as compound extraction, large-scale production, and clinical validation, must be addressed for effective drug development. The vast biological diversity of marine algae across different ocean ecosystems is a largely unexplored source of distinct chemical structures, which may be the basis for new therapeutic schemes. Despite their therapeutic potential, the translation of marine algae-derived compounds into clinical applications faces significant hurdles, including challenges in large-scale extraction, bioavailability enhancement, and regulatory approval. The need to extract particular compounds to make them available for large-scale production and to overcome issues such as bioavailability and regulatory policies are formidable challenges. Marine algae represent innovative advances in antiviral and anticancer drug development, but only when combined with ecologically sound cultivation methods, interdisciplinary approaches, and understanding. The integration of advanced biotechnological approaches, innovative gene editing techniques, and environmentally sustainable aquaculture practices is pivotal for harnessing the full potential of marine algae for the development of next-generation antiviral and anticancer therapeutics. Full article

Replacing traditional agricultural ingredients with biotechnologically improved agro-industry by-products in fish diets promotes sustainable aquaculture, reduces production costs and carbon footprint, and promotes a circular economy. Brewer’s spent grain (BSG) is one such by-product. Solid-state fermentation (SSF) of BSG with Aspergillus ibericus enhances its nutritional value and digestibility for European seabass. The present study further evaluates the potential of dietary inclusion of BSG-SSF on growth performance, feed utilization, plasma metabolite profile, intermediary metabolism, and oxidative status of European seabass juveniles compared to the unfermented product. A practical diet (45% protein; 18% lipids) was tested against diets incorporating 10% or 20% of BSG or BSG-SSF, replacing plant-protein feedstuffs. Triplicate groups of European seabass juveniles (49 g initial weight) were fed for 10 weeks. Unfermented BSG (10% and 20%) reduced growth and feed efficiency. In comparison, the 20% BSG-SSF diet promoted growth and feed efficiency similar to the control group, while the 10% BSG-SSF diet surpassed the control diet. Whole-body protein content was unaffected, but lipid and energy content decreased with increasing BSG levels, regardless of fermentation. Plasma glucose and phospholipid levels and hepatic activities of glucokinase and malic enzymes decreased with increasing BSG, irrespective of fermentation. BSG-SSF incorporation increased plasma triglyceride levels and decreased hepatic transaminase activities but did not affect hepatic key enzyme activity of β-oxidation or lipogenesis. It also reduced antioxidant enzyme activity and lipid peroxidation. In conclusion, BSG negatively impacted growth performance, while BSG-SSF supported inclusion levels up to 20% without performance loss. Further, the 10% BSG -SSF diet outperformed the control diet. Full article

Stutzerimonas kunmingensis TFRC-KFRI-1, isolated from the gut of Manila Clam in the sediment of the West Sea of Korea, was investigated for its potential as a probiotic bacterium. This strain, belonging to the family Pseudomonadaceae, was previously classified as Pseudomonas kunmingensis but later reclassified to the genus Stutzerimonas, known for species with bioremediation and probiotic properties. To evaluate its genomic features and potential applications, we performed draft-genome sequencing and analysis. The genome of S. kunmingensis TFRC-KFRI-1 was assembled into a 4,756,396 bp sequence with a 62.8% GC content. Genomic analysis suggested potential genes for carbohydrate degradation and lactic acid production. The strain exhibited high average nucleotide identity (ANI) and 16S rRNA similarity with S. kunmingensis HL22-2^T, further supporting its potential as a probiotic. This genome sequence provides valuable insights into the functional capabilities of S. kunmingensis TFRC-KFRI-1 and its potential applications in various industries, including aquaculture and food biotechnology. The genome sequence is available under GenBank accession number JBGJJB000000000.1, with related project information under BioProject PRJNA1147901 and Bio-Sample SAMN43173893. Full article

As aquaculture production grows, so does the demand for quality and cost-effective protein sources. The cost of fishmeal (FM) has increased over the years, leading to increased production costs for formulated aquafeed. Soybean meal (SBM) is commonly used as an FM replacer in aquafeed, but anti-nutritional factors could affect the growth, nutrition, and health of aquatic organisms. Cricket meal (CM) is an alternative source with a nutrient profile comparable to FM due to its high protein content, digestibility, and amino acid profile. CM use in aquafeed influences growth and reproductive performance while modulating the gut microbiota and immune response of fish and shrimp. However, consistent regulation and scaling up are necessary for competitive prices and the marketing of CM. Moreover, the chitin content in CM could be an issue in some fish species; however, different strategies based on food biotechnology can improve the protein quality for its safe use in aquafeed. Full article

A recirculating aquaculture system (RAS) represents a forward-looking form of aquaculture. A RAS consists of fish tanks and water treatment processes in a closed loop to sustain the environmental conditions for fish production. However, the rapid industrialization of the technology is fraught with transfer problems. This review justifies a RAS process chain based on fish biology. The underlying concept has been evaluated by the author in experimental and commercial RAS projects. The core idea is that the fish must be considered as a technical subcomponent in a RAS, determining the technology. Fish, when considered as small biological machines, are still a black box in many ways. However, their basic biology and physiology provide all the knowledge to implement them in a technical setting. The information required to understand this concept is presented and discussed based on current scientific knowledge. The conclusion is that the technology is available but needs to be rigorously implemented. If this were carried out, fish production in RASs would be ecologically sustainable, which is already claimed for RASs but is not always the reality in commercial applications. Full article